Hostname: page-component-6766d58669-kl59c Total loading time: 0 Render date: 2026-05-18T09:55:02.390Z Has data issue: false hasContentIssue false

Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009

Published online by Cambridge University Press:  22 March 2011

L. PEZZOLI*
Affiliation:
World Health Organization, Geneva, Switzerland
R. TCHIO
Affiliation:
Expanded Programme for Immunization, Ministry of Health, Yaoundé, Cameroon
A. D. DZOSSA
Affiliation:
National Institute of Statistics, Yaoundé, Cameroon
S. NDJOMO
Affiliation:
National Institute of Statistics, Yaoundé, Cameroon
A. TAKEU
Affiliation:
National Institute of Statistics, Yaoundé, Cameroon
B. ANYA
Affiliation:
Immunization, World Health Organization, Yaoundé, Cameroon
J. TICHA
Affiliation:
Immunization, World Health Organization, Yaoundé, Cameroon
O. RONVEAUX
Affiliation:
Immunization and Vaccine Development, World Health Organization, Ouagadougou, Burkina Faso
R. F. LEWIS
Affiliation:
Epidemic Readiness and Intervention, World Health Organization, Geneva, Switzerland
*
*Author for correspondence: Dr L. Pezzoli, Epidemiology Consultant, World Health Organization, Geneva, Switzerland. (Email: Lorenzo.pezz@gmail.com)
Rights & Permissions [Opens in a new window]

Summary

We used the clustered lot quality assurance sampling (clustered-LQAS) technique to identify districts with low immunization coverage and guide mop-up actions during the last 4 days of a combined oral polio vaccine (OPV) and yellow fever (YF) vaccination campaign conducted in Cameroon in May 2009. We monitored 17 pre-selected districts at risk for low coverage. We designed LQAS plans to reject districts with YF vaccination coverage <90% and with OPV coverage <95%. In each lot the sample size was 50 (five clusters of 10) with decision values of 3 for assessing OPV and 7 for YF coverage. We ‘rejected’ 10 districts for low YF coverage and 14 for low OPV coverage. Hence we recommended a 2-day extension of the campaign. Clustered-LQAS proved to be useful in guiding the campaign vaccination strategy before the completion of the operations.

Information

Type
Original Papers
Copyright
Copyright © Cambridge University Press 2011
Figure 0

Table 1. Sampling plans used to evaluate coverage of the two vaccines, clustered lot quality assurance sampling survey of yellow fever and polio vaccination coverage, Cameroon, May 2009

Figure 1

Fig. 1. Operating characteristic curves for lot quality assurance sampling rule-rejecting programmes with more than seven defectives in a sample of 50, according to simple random sampling (SRS) and the two 5×10 clustered designs (s.d.=0·05 and s.d.=0·10).

Figure 2

Fig. 2. Operating characteristic curves for lot quality assurance sampling rule-rejecting programmes with more than three defectives in a sample of 50, according to simple random sampling (SRS) and the two 5×10 clustered designs (s.d.=0·05 and s.d.=0·10).

Figure 3

Table 2. Classification for being at risk of low coverage and yellow fever vaccination coverage in the 17 districts retained for the clustered lot quality assurance sampling survey, Cameroon, May 2009

Figure 4

Table 3. Oral polio vaccination coverage findings of clustered lot quality assurance sampling survey, Cameroon, May 2009

Figure 5

Table 4. Yellow fever vaccination coverage findings of clustered lot quality assurance sampling survey, Cameroon, May 2009